Securities Code: 301246 Securities Abbreviation: Hongyuan Pharmaceutical Announcement Number: 2026-029
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. 2025 Annual Equity Distribution Implementation Announcement
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Special Notice:
- In accordance with the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 9—Repurchase of Shares," and other relevant regulations, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company" or "this Company") will not participate in this equity distribution with the 3,200,000 shares in the dedicated securities account for repurchases. This equity distribution will be based on the Company's existing total share capital of 400,006,800 shares, excluding the 3,200,000 shares in the dedicated securities account for repurchases, resulting in a share capital of 396,806,800 shares. A cash dividend of RMB 0.50 (tax inclusive) will be distributed per 10 shares to all shareholders. The actual total cash dividend distributed will be RMB 19,840,340.00 = 396,806,800 shares × RMB 0.50 / 10 shares.
- When calculating the ex-rights and ex-dividend price after this equity distribution, the cash dividend per 10 shares converted based on the Company's total share capital (including repurchased shares) is calculated as: Total cash dividend ÷ Total share capital (including repurchased shares) × 10 shares = RMB 19,840,340.00 ÷ 400,006,800 shares × 10 shares = 0.496000 RMB (retaining six decimal places, truncating the last digit directly, without rounding). The ex-rights and ex-dividend reference price after this equity distribution will be: Closing price on the equity registration date for dividend distribution - cash dividend per share = Closing price on the equity registration date for dividend distribution - 0.0496000 RMB/share.
The Company's 2025 annual equity distribution plan was approved at the 2025 Annual Shareholders' Meeting held on May 20, 2026. For details, please refer to the "Resolution Announcement of the 2025 Annual Shareholders' Meeting" (Announcement Number: 2026-022) disclosed on the same day on the designated information disclosure media of the China Securities Regulatory Commission, Juchao Information Network (www.cninfo.com.cn). The equity distribution matters are hereby announced as follows: